| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |